Marc Amsler
Marc Amsler (1891–1968) was a Swiss ophthalmologist renowned for his contributions to the field of ophthalmology, particularly in the study and treatment of corneal diseases and macular degeneration. He is best known for developing the Amsler grid, a diagnostic tool used to detect visual field defects and monitor changes in the macula.
Early Life and Education[edit]
Marc Amsler was born in 1891 in Switzerland. He pursued his medical education at the University of Lausanne, where he developed an interest in ophthalmology. After completing his studies, Amsler trained under prominent ophthalmologists, which laid the foundation for his future contributions to the field.
Career[edit]
Amsler's career in ophthalmology began in earnest when he joined the faculty at the University of Zurich. His work focused on the anatomy and physiology of the eye, with a particular emphasis on the cornea and retina.
Contributions to Ophthalmology[edit]
Amsler's most significant contribution is the development of the Amsler grid, a simple yet effective tool for detecting macular degeneration and other retinal disorders. The grid is used by patients to self-monitor their central vision and report any distortions or changes to their ophthalmologist.
In addition to the Amsler grid, Marc Amsler conducted extensive research on keratoconus, a progressive eye disease that affects the shape of the cornea. His studies helped improve the understanding and management of this condition.
Legacy[edit]
Marc Amsler's work has had a lasting impact on the field of ophthalmology. The Amsler grid remains a standard tool in eye care, used worldwide by ophthalmologists and optometrists. His research on corneal diseases continues to influence modern treatments and diagnostic techniques.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian